Statistics
Publications
109
Citations
22.1K
H-Index
61
Active since
1996
David A. Barbie is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
1996–2025
109
109
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie, Pablo Tamayo, Jesse S. Boehm et al. · Nature · 2009 · 4.2K citations · Full text
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text
Life Sciences, Immunology, Oncology +14
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco et al. · Cell · 2018 · 1.4K citations · Full text
Medicine, Cancer Biology, Oncology +12
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng, Eric S. Wang, Russell W. Jenkins et al. · Cancer Discovery · 2017 · 781 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 109